Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70468 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by Emilie Høegholm Ernst Lauridsen and 7 co-authors. Institution: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Major MEDLINE topics: Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Biomarkers, Antigens, CD. 49 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Svend Andersen Fonden, Kirsten og Freddy Johansens Fond, Rigshospitalet.
Abstract (original language)
Background and Aims Post liver transplantation (LT) inflammation and fibrosis are clinical challenges that may affect long‐term outcomes. We aimed to investigate sCD163 as a biomarker of liver fibrosis in LT recipients and compare it with the Fibrosis 4 (FIB‐4) score and FibroScan. Methods In the Danish Comorbidity in Liver Transplant Recipients study (DACOLT) we included 105 LT recipients at Aarhus University Hospital. We reviewed patient records and collected plasma for measurements of sCD163 and FIB‐4. Liver stiffness was assessed using FibroScan. Liver biopsies performed
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Infectious Diseases 8632, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, København K, Denmark.
- Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Surgical of Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
ORCID profiles: Emilie Høegholm Ernst Lauridsen, Moises Alberto Suarez-Zdunek
Funding
- Svend Andersen Fonden
- Kirsten og Freddy Johansens Fond
- Rigshospitalet
- Novo Nordisk Fonden
Cite
APA
Lauridsen, E. H. E., Gantzel, R. H., Suarez-Zdunek, M. A., Nielsen, M. B., Rasmussen, A., Nielsen, S. D., Grønbæk, H., & Villadsen, G. E. (2026). Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70468
Vancouver
Lauridsen EHE, Gantzel RH, Suarez-Zdunek MA, Nielsen MB, Rasmussen A, Nielsen SD, et al. Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients. Clinical Transplantation. 2026. doi:10.1111/ctr.70468
BibTeX
@article{Lauridsen2026,
author = {Lauridsen, Emilie Høegholm Ernst and Gantzel, Rasmus Hvidbjerg and Suarez-Zdunek, Moises Alberto and Nielsen, Mette Bak and Rasmussen, Allan and Nielsen, Susanne Dam and Grønbæk, Henning and Villadsen, Gerda Elisabeth},
title = {Soluble CD163 as a Biomarker of Liver Fibrosis and Inflammation in Liver Transplant Recipients},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70468}
}
EUVIMED